MercoPress, en Español

Montevideo, March 28th 2024 - 14:26 UTC

 

 

Sao Paulo University to test a potential coronavirus vaccine developed by Italian lab

Friday, June 26th 2020 - 09:23 UTC
Full article
The Italian researchers want to conduct mid-stage trials and final Phase III studies involving thousands of subjects in Brazil, Smaili said. The Italian researchers want to conduct mid-stage trials and final Phase III studies involving thousands of subjects in Brazil, Smaili said.

The Federal University of Sao Paulo (Unifesp) is in talks to test a potential coronavirus vaccine developed by Italian researchers, the dean of the Brazilian university revealed.

With the world's worst outbreak outside the United States, Brazil has become a key front in the global race for a vaccine, as vaccine clinical trials are likely to yield results faster in places where the virus is widespread.

“We are already in advanced discussions with Italy's Lazzaro Spallanzani National Institute,” Unifesp President Soraya Smaili said in an interview on Wednesday. “We expect to bring it here, the accord is already moving forward and we'll be able to do a lot of studies with this vaccine.”

The Italian researchers want to conduct mid-stage trials and final Phase III studies involving thousands of subjects in Brazil, Smaili said.

Over the weekend, Unifesp began clinical trials of a vaccine developed by Oxford University with support from AstraZeneca. Brazil's government is nearing an agreement to eventually produce that vaccine.

Unifesp is also working on early development of a Brazilian vaccine led by the University of Sao Paulo, a separate university with ties to the state government.

Top Comments

Disclaimer & comment rules

Commenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!